1. Home
  2. INTZ vs SER Comparison

INTZ vs SER Comparison

Compare INTZ & SER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intrusion Inc.

INTZ

Intrusion Inc.

HOLD

Current Price

$0.88

Market Cap

21.3M

ML Signal

HOLD

Logo Serina Therapeutics Inc.

SER

Serina Therapeutics Inc.

SELL

Current Price

$2.27

Market Cap

19.4M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
INTZ
SER
Founded
1983
2017
Country
United States
United States
Employees
N/A
13
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
21.3M
19.4M
IPO Year
2020
N/A

Fundamental Metrics

Financial Performance
Metric
INTZ
SER
Price
$0.88
$2.27
Analyst Decision
Buy
Strong Buy
Analyst Count
2
1
Target Price
$7.25
$15.00
AVG Volume (30 Days)
156.4K
7.1M
Earning Date
03-24-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
71.78
N/A
EPS
N/A
N/A
Revenue
$7,015,000.00
N/A
Revenue This Year
$35.44
N/A
Revenue Next Year
$23.57
N/A
P/E Ratio
N/A
N/A
Revenue Growth
21.56
N/A
52 Week Low
$0.75
$1.22
52 Week High
$2.64
$7.92

Technical Indicators

Market Signals
Indicator
INTZ
SER
Relative Strength Index (RSI) 37.74 52.31
Support Level $0.81 $1.49
Resistance Level $1.17 $3.10
Average True Range (ATR) 0.13 0.36
MACD -0.03 0.12
Stochastic Oscillator 4.13 50.73

Price Performance

Historical Comparison
INTZ
SER

About INTZ Intrusion Inc.

Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Share on Social Networks: